Advertisement
| cosentyx instructions for use: Biosimilars Hiten J. Gutka, Harry Yang, Shefali Kakar, 2018-12-13 This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars. The development path of a biosimilar is just as unique as a development path of a new drug, tailored by the mechanism of action, the quality of the molecule, published information on the reference product, the current competitive environment, the target market and regulatory guidance, and most importantly, the emerging totality of evidence for the proposed biosimilar during development. For the ease of readers, the book comprises of six sections as follows: Section I: Business, Health Economics and Intellectual Property Landscape for Biosimilars Section II: Regulatory Aspects of Development and Approval for Biosimilars Section III: Biopharmaceutical Development and Manufacturing of Biosimilars Section IV: Analytical Similarity Considerations for Biosimilars Section V: Clinical aspects of Biosimilar Development Section VI: Biosimilars- Global Development and Clinical Experience Chapters have been written by one or more experts from academia, industry or regulatory agencies who have been involved with one or more aspects of biosimilar product development. The authors and editors have an expertise in commercialization and pricing of biosimilars, intellectual property considerations for biosimilars, chemistry manufacturing controls (CMC) and analytical development for biosimilars, regulatory and clinical aspects of biosimilar development. Besides the industry practitioners, the book includes several contributions from regulators across the globe. |
| cosentyx instructions for use: Complete Guide to Prescription & Nonprescription Drugs 2018-2019 H. Winter Griffith, 2017-11-07 The classic guide to all major prescription and nonprescription drugs, featuring revised, up-to-date FDA information and an A–Z list of illnesses for easy reference. Includes coverage of dosage and length of time before a drug takes effect; side effects; special precautions; interactions with other food and drugs; standards for use by different age groups; and more. |
| cosentyx instructions for use: Handbook of Pharmaceutical Public Policy Thomas Fulda, 2007-07-25 Get an invaluable view of the impact of economics and politics on pharmaceuticals in the United States Pharmacy and pharmaceutical drug use are highly regulated and the various regulatory forces interact with diverse goals. Pharmaceutical Public Policy is a comprehensive review of the legislation, trends, business developments, and policy interpretations that have shaped drug use during the last 50 years. This unique single source explains drug regulatory activity, the major insurance and payment systems, and the impact of economics and politics on drug use in the United States. Leading experts provide a thorough and objective look at public policy issues, making this text perfect for upper level undergraduate and graduate level pharmacy, medical, and public health educators and students. Pharmacists and pharmacy students must learn more than just the physical sciences and clinical aspects of the pharmaceutical industry. The rationale for policies, rules, and regulations is integral to understanding how to best serve patients and make the entire pharmaceutical sector more equitable and cost-effective. Pharmaceutical Public Policy examines the most pressing issues facing the industry, including control of the rising costs for drugs and ensuring correct drug usage by patients. This insightful text offers an in depth perspective of the policies and the debates that surround them. Chapters are well-referenced and many include helpful figures and tables to illustrate facts and ideas. Topics in Pharmaceutical Public Policy include: pharmacy law and regulation Medicare and prescription drug coverage FDA drug approval process Medicaid and prescription drugs public health pharmacy Department of Veterans Affairs pharmacy programs Department of Defense pharmacy programs innovative state drug program practices state and federal regulation of pharmacy the future of the pharmaceutical industry managed care pharmacy PBM’s (pharmacy benefit managers) risk minimization importation and reimportation biotechnology and pharmacogenetics policy and issues product promotion competition between drugs drug insurance design patient compliance abuse of prescription drugs health care systems and insurance in Europe much more Pharmaceutical Public Policy is a one-of-a-kind resource that explains just who the players are and the complexity of the issues that are examined in most pharmaceutical policy debates, and is perfect for pharmacy students, educators, other health professionals, trade association leaders, and policymakers. |
| cosentyx instructions for use: Complete Guide to Prescription & Nonprescription Drugs 2016-2017 H. Winter Griffith, 2015-11-17 The classic guide to all major prescription and nonprescription drugs, featuring revised, up-to-date FDA information and an A–Z list of illnesses for easy reference. Includes coverage of dosage and length of time before a drug takes effect; side effects; special precautions; interactions with other food and drugs; standards for use by different age groups; and more. From the Trade Paperback edition. |
| cosentyx instructions for use: Biologics, Biosimilars, and Biobetters Iqbal Ramzan, 2021-02-03 A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective. Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists |
| cosentyx instructions for use: Development of Biopharmaceutical Drug-Device Products Feroz Jameel, John W. Skoug, Robert R. Nesbitt, 2020-03-13 The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T-cell engager (BITES), Dual Variable Domain (DVD) antibodies, and fusion proteins that are currently being used as therapeutic agents for immunology, oncology and other disease conditions. Regulatory agencies have raised the bar for the development and manufacture of antibody-based products, expecting to see the use of Quality by Design (QbD) elements demonstrating an in-depth understanding of product and process based on sound science. Drug delivery systems have become an increasingly important part of the therapy and most biopharmaceuticals for self-administration are being marketed as combination products. A survey of the market indicates that there is a strong need for a new book that will provide “one stop shopping” for the latest information and knowledge of the scientific and engineering advances made over the last few years in the area of biopharmaceutical product development. The new book entitled Development of Biopharmaceutical Drug Device Products is a reference text for scientists and engineers in the biopharmaceutical industry, academia or regulatory agencies. With insightful chapters from experts in the field, this new book reviews first principles, covers recent technological advancements and provides case studies and regulatory strategies relating to the development and manufacture of antibody-based products. It covers topics such as the importance of early preformulation studies during drug discovery to influence molecular selection for development, formulation strategies for new modalities, and the analytical techniques used to characterize them. It also addresses important considerations for later stage development such as the development of robust formulations and processes, including process engineering and modeling of manufacturing unit operations, the design of analytical comparability studies, and characterization of primary containers (pre-filled syringes and vials).Finally, the latter half of the book reviews key considerations to ensure the development and approval of a patient-centered delivery system design. This involves the evolving regulatory framework with perspectives from both the US and EU industry experts, the role of international standards, design control/risk management, human factors and its importance in the product development and regulatory approval process, as well as review of the risk-based approach to bridging between devices used in clinical trials and the to-be-marketed device. Finally, case studies are provided throughout.The typical readership would have biology and/or engineering degrees and would include researchers, scientific leaders, industry specialists and technology developers working in the biopharmaceutical field. |
| cosentyx instructions for use: WHO Best Practices for Injections and Related Procedures Toolkit , 2010 The new WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks. The main areas covered by the toolkit are: 1. bloodborne pathogens transmitted through unsafe injection practices;2. relevant elements of standard precautions and associated barrier protection;3. best injection and related infection prevention and control practices;4. occupational risk factors and their management. |
| cosentyx instructions for use: Practical Guide to Dermatology Henry W. Lim, Laurie L. Kohen, Samantha L. Schneider, Danielle Yeager, 2019-10-02 This practical manual provides a real-world educationally focused resource. It enables the reader to gain a good understanding of a range of skin diseases, their differential diagnosis and various medical and/or surgical treatment options. Topics covered include general dermatology, oncodermatology, drugs, phototherapy, pigmentary disorders, skin of color, inpatient dermatology and pediatric dermatology. Emphasis is placed on concise, practical points that one can use in clinic, with informative pearls to reinforce the key messages in each chapter. Practical Guide to Dermatology: The Henry Ford Manual systematically describes a broad range of practical concepts, diagnostic and treatment techniques involving various dermatological disciplines. It represents a valuable reference guide for practising and trainee dermatologists alike. |
| cosentyx instructions for use: Immunologic Concepts in Transfusion Medicine Robert W Maitta, 2019-08-27 Immunological Concepts in Transfusion Medicine provides a thorough discussion of the immune aspects of blood component transfusion, with in-depth information on the intricacies of immune responses to blood components and the immune processes that may be initiated in response to blood exposure. Written to increase knowledge and awareness of immune challenges such as alloimmunization and transfusion-related acute lung injury, this title bridges current basic scientific discoveries and the potential effects seen in blood recipients. - Complies the knowledge and expertise of Dr. Robert Maitta, an expert in immune responses and antibody function/structure studies. - Helps clinicians in the daily practice of caring for patients in need of transfusion support, as well as physicians in training when considering utilizing blood transfusions in a limited scope or in the setting of massive transfusion. - Includes an immunology primer as an introduction to in-depth chapters covering allergic immune reactions to blood components, transfusion-related immunomodulation, fetal and neonatal alloimmune thrombocytopenia and neonatal neuthropenia, complications of haploidentical and mismatched HSC transplantation, chimeric antibody receptor therapies, and much more. - Consolidates today's available information on this timely topic into a single, convenient resource. |
| cosentyx instructions for use: Methadone Treatment for Opioid Dependence Eric C. Strain, Maxine L. Stitzer, 1999 Throughout the world, hundreds of thousands of people are addicted to opiates. The human, economic, and societal costs of this addiction are staggering: more than one-quarter of prison inmates are incarcerated for drug offenses and there has been a dramat. |
| cosentyx instructions for use: Pharmacology of Immunotherapeutic Drugs Clinton B. Mathias, Jeremy P. McAleer, Doreen E. Szollosi, 2019-10-18 Medicine has entered a golden age in which therapeutic agents are becoming widely available due to advances in basic science and technology. As such, many drugs have been developed that target inflammatory processes and/or the immune system. This book is intended for health professionals examining the modulation of inflammation by immunotherapeutic drugs. The immune system fills the primordial role of host defense and resistance to infections with pathogenic microorganisms. Several hematopoietic-derived cells constituting the innate and adaptive immune systems cooperate to provide barriers for microbial colonization and/or promote pathogen destruction within the host. Conversely, many immune cells are also involved in the pathogenesis and propagation of chronic inflammatory diseases. The beginning of this book details various components of the immune system including the cell types, lymphoid tissues, soluble cytokines and surface molecules that are essential for host defense. Breakdowns in immune tolerance, or dysregulated immune responses to antigens derived from self tissues or innocuous sources, can lead to the development of autoimmunity or chronic inflammatory diseases. Pathophysiologic roles for the immune system are detailed in corresponding chapters on autoimmunity, epithelial surfaces (lungs, skin, intestine), and transplantation, with special emphasis placed on immunotherapeutic drug targets. The last section of the book focuses on treatments that stimulate our immune system to specifically target and fight infectious diseases and cancer. In each chapter, the medications used to treat various diseases/conditions in terms of their mechanism of action and other pharmacologic properties are detailed. Chapters begin with a table showing drug names and classifications. The importance of basic science and clinical trials cannot be understated in the context of drug development. As such, the discovery of certain medications that had a lasting impact in medicine and pharmacy are highlighted in chapter subsections named “Bench to Bedside.” Several clinical applications of immunotherapeutic drugs are described within end-of -chapter case studies including practice questions. The Pharmacology of Immunotherapeutic Drugs is a reference for immunologists and clinicians (medical doctors, pharmacists, nurses) examining the modulation of inflammatory processes by a variety of medications targeting the cells and mediators of our immune system. |
| cosentyx instructions for use: Biologic Therapy for Psoriasis Nicholas Brownstone, Tina Bhutani, Wilson Liao, 2022-02-17 Biologic therapy is a treatment that strives to modulate a patient's immune system to fight a given disease. In psoriasis, a skin disorder that is partly caused by a dysregulated immune system resulting in well-demarcated red areas of the skin with white scales, biologic therapy has the potential to vastly improve upon patient outcomes by minimizing the symptoms of this disease while maximizing the safety profile of the therapy. This book offers an up-to-date and comprehensive review on biologic therapy for the treatment of psoriasis. With over 10 FDA approved biologic agents for psoriasis (with more in the pipeline), confusion exists among providers regarding which agent is best for a particular patient. Chapters cover all FDA approved psoriasis biologic agents (including pipeline agents) for use in pediatric, adult, and geriatric patients. This book is unique in that it will not only cover cutting edge treatment principles based on the latest research, it will also be one of the most comprehensive reviews of psoriasis biologics in the COVID-19 era. Biologic Therapy for Psoriasis is a must-have resource for board certified dermatologists and rheumatologists, dermatology and rheumatology residents and fellows, dermatology physician assistants, nurse practitioners and medical students. The ultimate goal of this book is to improve patient care by making the busy practicing dermatology provider more adept with these particular therapies. |
| cosentyx instructions for use: Management of Psoriasis Nikhil Yawalkar, 2009 Treatments for psoriasis, besides affecting the skin, may be associated with various comorbidities (for instance, depression, psoriatic arthritis, Crohn's disease and, in severe psoriasis, metabolic syndrome and cardiovascular diseases), which often presents a therapeutic challenge to physicians.Written by renowned experts, this volume gives a comprehensive overview of psoriasis and its various comorbidities. It describes the treatment modalities for mild and moderate-to-severe psoriasis, including topical, phototherapeutic and conventional systemic treatments (e.g. acitretine, methotrexate and cyclosporine), as well as biological therapies (e.g. alefacept, efalizumab, etanercept, adalimumab and infliximab). The chapters on biological therapies focus on key safety issues. Further chapters focus on such topics as the management of childhood psoriasis and psoriasis in distinctive locations, such as the scalp, face, flexures, palm/soles and nails. Finally, future therapeutic modalities, with the focus on small molecules and potential biological therapies, are discussed.This publication will make significant reading to dermatologists and all physicians dealing with psoriasis, such as general practitioners, psychiatrists, rheumatologists, cardiologists and diabetologists. |
| cosentyx instructions for use: Biological Drug Products Wei Wang, Manmohan Singh, 2013-08-29 Tested and proven solutions to the challenges of biological drug product development Biological drug products play a central role in combating human diseases; however, developing new successful biological drugs presents many challenges, including labor intensive production processes, tighter regulatory controls, and increased market competition. This book reviews the current state of the science, offering readers a single resource that sets forth the fundamentals as well as tested and proven development strategies for biological drugs. Moreover, the book prepares readers for the challenges that typically arise during drug development, offering straightforward solutions to improve their ability to pass through all the regulatory hurdles and deliver new drug products to the market. Biological Drug Products begins with general considerations for the development of any biological drug product and then explores the strategies and challenges involved in the development of specific types of biologics. Divided into five parts, the book examines: Part 1: General Aspects Part 2: Proteins and Peptides Part 3: Vaccines Part 4: Novel Biologics Part 5: Product Administration/Delivery Each chapter has been prepared by one or more leading experts in biological drug development. Contributions are based on a comprehensive review and analysis of the current literature as well as the authors' first-hand experience developing and testing new drugs. References at the end of each chapter serve as a gateway to original research papers and reviews in the field. By incorporating lessons learned and future directions for research, Biological Drug Products enables pharmaceutical scientists and students to improve their success rate in developing new biologics to treat a broad range of human diseases. |
| cosentyx instructions for use: Manual for Pharmacy Technicians Bonnie S. Bachenheimer, 2019-08-15 The Trusted Training Resource for Pharmacy Technicians at All Levels The role of pharmacy technicians is rapidly expanding, and demand for well-trained technicians has never been higher! Technicians are assuming more responsibilities and are taking on greater leadership roles. Quality training material is increasingly important for new technicians entering the field, and current technicians looking to advance. Look no further than the new 5th edition of the best-selling Manual for Pharmacy Technicians to master the practical skills and gain the foundational knowledge all technicians need to be successful. |
| cosentyx instructions for use: Moderate to Severe Psoriasis John Koo, Jashin Wu, Alice Gottlieb, Ethan Levin, Argentina Leon, 2014-03-18 Written by experts in the dermatology field, this new fourth edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and other pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. Illustrated with high quality color figures, this standalone text emphasizes safe and effective treatments for the psoriasis |
| cosentyx instructions for use: High Density Lipoproteins Arnold von Eckardstein, Dimitris Kardassis, 2015-01-13 In this Handbook of Experimental Pharmacology on “High Density Lipoproteins – from biological understanding to clinical exploitation” contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases. |
| cosentyx instructions for use: Mild to Moderate Psoriasis John Y. M. Koo, Ethan C. Levin, Argentina Leon, Jashin J. Wu, Mark G. Lebwohl, 2014-03-18 Using a practical and problem-focused approach, this updated, full-color Third Edition of Mild-to-Moderate Psoriasis equips dermatologists, internists, family practitioners, and residents with a state-of-the-art guide to the clinical management of mild-to-moderate psoriasis.Written by an international team of key opinion leaders, this resource explores new developments in treatments for the condition and provides clinicians with up-to-date strategies for optimal patient management. |
| cosentyx instructions for use: Treatment of Non-infectious Uveitis Phoebe Lin, Eric Suhler, 2019-09-12 This unique, comprehensive book provides a much-needed reference on the treatment and management of non-infectious uveitis. Carefully designed, Treatment of Non-infectious Uveitis is the first book of its kind to provide an in-depth, clinically-relevant, expert-driven resource for ophthalmologists focusing on modalities of uveitis treatment, their mechanism of action, dosing, and side effects. Each chapter provides an introduction, mechanism of action, indication, dosage, side effects, and efficacy summaries from clinical trials and other published literature. Topics range from topical treatment, to locally administered therapy including drug-releasing implants, to systemic immunosuppressive treatments both tried and new, as well as surgical management, with each chapter highlighting important practice pearls as well as easy-reference dosing tables, side effects, and lab monitoring pertinent to the agents discussed. The book concludes with a discussion of novel approaches to the treatment of non-infectious uveitis, and special considerations when treating uveitis in the pediatric patient. The majority of patients with non-infectious uveitis are treated by comprehensive ophthalmologists, many of whom are less familiar with established treatment guidelines outlining the role of corticosteroids and immunomodulatory therapy. While the non-specialist, resident, or fellow is sure to benefit from this one-stop guide to uveitis treatment, retina and uveitis specialists alike will also appreciate the practice tips and thorough coverage of this expertly-written reference. Treatment of Non-infectious Uveitis is the ideal reference for all ophthalmologists who seek to improve their understanding of the causes of uveitis and learn how to best treat this condition. |
| cosentyx instructions for use: Biologic and Systemic Agents in Dermatology Paul S. Yamauchi, 2018-01-02 Written by leading experts in the field and designed for dermatologists and residents, this book includes evidence-based medicine that underscores the clinical data, as well as practical tips on how to use both biologic and systemic agents in the field of dermatology. In the past decade, there have been several groundbreaking advances in medical dermatology. Novel biologic and systemic agents have been developed to treat inflammatory disorders, including psoriasis and atopic dermatitis, as well as skin malignancies such as melanoma. Biologic and Systemic Agents in Dermatology encompasses these developments by describing the mechanism of action of these various agents and the clinical efficacy and safety to treating these respective disorders. The utilization of biologic and systemic agents in other dermatologic conditions, pharmacoeconomics, pharmacovigilance, and clinical trials outcomes are discussed as well as topics including tumor necrosis, conventional systemic agents for psoriatic disease, and oral agents for atopic dermatitis. |
| cosentyx instructions for use: Musculoskeletal Infection John L. Esterhai, Anthony G. Gristina, Robert Poss, 1992 This text provides a guide to understanding the mechanisms involved in the pathogenesis of muscoskeletal sepsis. It covers areas such as bone, cartilage, soft tissue, and biomaterial interaction in the face of infection. |
| cosentyx instructions for use: Outside the Box Cancer Therapies Dr. Mark Stengler, 2019-05-07 Now in paperback: A thorough, cutting-edge, alternative therapy-focused exploration of Integrative Oncology care. With approximately 40 percent of men and women in the United States being diagnosed with cancer at some point in their lifetime, very few of us escape having cancer touch our lives in some way--whether it is our own life or that of a loved one. Scientific research continues to prove the benefits of nutritional and holistic therapies, yet, for the most part, these approaches to treatment still remain unexplored by the conventional medical establishment. With integrative and holistic healing being sought after and supported by more and more of the general public and medical community for various elements of everyday life, it only makes logical sense to explore these therapies with regard to one of the most prevalent causes of death of our time. In Outside the Box Cancer Therapies, naturopathic medical doctors Mark Stengler and Paul Anderson combine their expertise to focus on the most critical components of integrative oncology care. Supported by extensive research and decades of clinical experience, Dr. Stengler and Dr. Anderson thoroughly explain: • the different types of cancer and their causes • how proper nutrition can help to prevent and treat cancer • the most well-studied supplements to use with cancer treatment • cutting-edge naturopathic therapies, and • natural solutions to common problems, such as the side effects of chemotherapy and radiation With a clear and focused approach, Dr. Stengler and Dr. Anderson provide a definitive and comprehensive resource for anyone seeking to heal from cancer or a professional looking for the most cutting, up-to-date integrative approaches to treatment. |
| cosentyx instructions for use: NCLEX-RN Exam Cram Wilda Rinehart, Diann Sloan, Clara Hurd, 2010-11-16 1200+ Questions with Detailed Answers Covers exactly what you need to know to score higher on your NCLEX-RN® exam. Includes more than 1,250 sample test questions to help you determine whether you’re ready to take the actual exam. Our popular Cram Sheet tear card helps you remember key concepts and facts. Use our innovative Quick-Check Answer Key SystemTM to quickly find answers as you work your way through the questions. Written by Leading Nursing Experts! Wilda Rinehart has R.N., B.S.N., M.S.N., F.N.C., and F.P.N.P. degrees. Her experience includes staff nurse in surgery, labor, and delivery; public-health nurse; and family-planning nurse practitioner. She also was an instructor of surgical and obstetrical nursing. Diann Sloan has R.N., B.S.N., M.S.N., F.N.C., as well as MS. Ed. and Ph.D. in Education degrees. She has worked as a staff nurse in surgical nursing, pediatrics, and neonatal intensive care and as a pediatric nurse clinician. She has also been an instructor of pediatric and psychiatric nursing. Clara Hurd has R.N., B.S.N., M.S.N., and G.N.C. degrees. She is currently serving as an item-writing consultant with Prentice Hall Publishing. She has 31 years of experience and has worked as a staff nurse in medical-surgical nursing and the surgical intensive care unit. Ms. Hurd has taught in associate and baccalaureate nursing programs. Score Higher on the NCLEX-RN® Exam! Category: Test Preparation and Review Covers: Nursing NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. (NCSBN), which does not sponsor or endorse this product. |
| cosentyx instructions for use: Adverse Reactions to Biologics L. Puig, W. Gulliver, 2017-11-07 In many areas of medicine physicians still face the great challenge of finding therapies that will meet the patients’ needs. In dermatology the challenge has arisen on multiple fronts through advances in the understanding of the immunopathogenesis of many inflammatory and malignant cutaneous disorders. Breakthroughs, combined with significant developments in targeted immunotherapy, have resulted in improved outcomes as these newer therapies are being used for both approved indications and as off-label therapies for various chronic inflammatory skin disorders and many forms of skin cancer. In the expectation that by truly understanding the safety profile of these targeted therapies patients’ outcomes will be significantly improved, this book offers insights into topics such as adverse reactions, infectious complications and the perioperative use of biologics in psoriasis, immunogenicity of biologic therapies, paradoxical reactions, safety of biologics used to treat autoimmune bullous diseases and primary cutaneous lymphomas, adverse reactions and skin manifestations of therapies targeting melanoma and non-melanoma skin cancer and other neoplastic diseases. Eminent researchers with extensive clinical experience have contributed to this publication, providing an in-depth overview of the latest knowledge in this field. |
| cosentyx instructions for use: British Pharmaceutical Codex , 1907 |
| cosentyx instructions for use: Selective COX-2 Inhibitors Sir John R. Vane, Jack H. Botting, 2012-12-06 The mainstay of therapy for rheumatoid disease is the non-steroid antiinflammatory drugs (NSAIDs), despite their inherent gastrointestinal toxicity and ability to cause renal damage in susceptible patients. The theory that the beneficial and toxic effects of NSAIDs stem from a reduction in prostanoid production through inhibition of cyclooxygenase implied that particular toxicities were inevitable with NSAIDs and would always be correlated with efficacy. However, over the years, it became apparent that at therapeutic doses, some NSAIDs had greater toxic side-effects than others, a fact not explained by the general theory. A significant clarification arose from the discovery that there are two distinct isoforms of COX, a constitutive enzyme (COX-I) responsible for the production of prostanoids necessary for platelet aggregation and protection of the gastric mucosa and kidney; and an inducible enzyme (COX-2) that is newly synthesized at sites of tissue damage and produces prostaglandins that manifest pathological effects. It became clear that different NSAIDs had greater or lesser effects on COX-I when used in therapeutic doses, explaining the variation in side-effects. ' The elucidation of the crystal structure of these different enzymes and the skills of medicinal chemists have led to the synthesis of new chemicals with a selectivity for the inducible enzyme, and thus with therapeutic efficacy without those toxic effects result ing from inhibition of the constitutive enzyme. |
| cosentyx instructions for use: Immunogenicity of Biopharmaceuticals Marco Weert, Eva Horn Møller, 2008-03-21 Immunogenicity of Biopharmaceuticals is the first book to comprehensively address the potential of an immune response to biopharmaceuticals. It is intended to give a broad overview of the current state-of-the-art regarding this subject. The chapters range from an overview of the immune system and factors that may trigger the immune system, via detection of antibodies and clinical implications, to various case examples and the regulatory view on immunogenicity. |
| cosentyx instructions for use: Herpes Simplex Infections of the Eye Frederick Christopher Blodi, 1984 |
| cosentyx instructions for use: Dermatologic Nursing Essentials Noreen Nicol, 2016-02-02 An official publication of the Dermatology Nurses Association, Dermatologic Nursing Essentials: A Core Curriculum is the definitive source for concepts and practices in dermatology nursing. It serves as an excellent review tool for certification, as well as day-to-day interaction with patients. Chapters include coverage of anatomy and physiology of the skin; skin assessment and diagnostic techniques; therapeutic/treatment modalities; diseases of the epidermis; dermatitis/eczemas; cutaneous malignancies; benign neoplasms/hyperplasia; cutaneous manifestations of systemic disease; connective tissue disorders; pediatric dermatology/acne; infections; aging skin; biologics; disorders of pigmentation; bites, stings, and infestations; cutaneous manifestations of HIV; wound healing; and psychosocial effects of dermatologic disease and psychodermatoses. |
| cosentyx instructions for use: Saunders Nursing Drug Handbook 2020 Robert Kizior, Keith Hodgson, 2019-02-27 The go-to guide for students and nurses alike to promote better patient care! Saunders Nursing Drug Handbook 2020 provides you with essential information on more than 1,000 generic and 4,000 trade name drugs. This handy user-friendly guide features updated Black Box Alerts and comprehensive coverage of IV drug administration, nursing considerations, and fixed combinations. It uniquely guides you through clinical priorities in the practice setting and is organized alphabetically by generic drug name for quick reference. Detailed information for each drug distinguishes side effects and adverse reactions and lists the effect or reaction by frequency of occurrence to allow the nurse to easily identify which are most likely to occur. Plus, new drug monographs cover approximately 32 newly approved drugs by the FDA; and thoroughly updated monographs include new interactions, precautions, and alerts. - Over 1,000 generic name drugs (encompassing over 4,000 trade name drugs) are organized alphabetically with A to Z tabs to make accessing important information quick and easy. - Detailed information for each drug distinguishes side effects and adverse reactions to help you identify which are most likely to occur. - Special text treatment for high-alert drugs that pose the greatest risk for patient harm, as well as an appendix for drug names that sound alike and look alike, help promote safe drug administration. - UNIQUE! Frequently-used herb monographs and herb interactions keep you informed of the effects of commonly encountered herbs.Classifications s - ection features an overview of actions and uses for drug families.T - op 100 Drugs list helps you easily identify the most frequently administered drugs.N - ursing implications are organized in a functional nursing process framework and include headings for Baseline Assessment, Intervention/Evaluation, and Patient/Family Teaching. - Information on lifespan and disorder-related dosage variations equips you with special considerations for pediatric, geriatric, hepatic, and immune-or renal-compromised patients. - Extensively expanded IV content features a heading for IV compatibilities and expanded rates of infusion, reconstitutions, drip rates, test doses, flushing, and incompatibilities. - Fixed combinations are included in dosages of each combined drug directly within the individual monographs to help you understand different drug dose options for specific diseases. - Cross-references to the 400 top U.S. brand-name drugs are located directly in the main section of the book for easier accessibility. - Customizable and printable monographs for 100 of the most commonly used drugs and quarterly drug updates are located on the free Evolve companion site. - Therapeutic and toxic blood level information shows students the patient implications for drug administration. - Comprehensive IV Compatibility Chart foldout arms you with compatibility information for 65 intravenous drugs. - Newly approved drugs are listed in the front of the book for quick and easy access to this timely information. - Highlights the features of a sample drug monograph with callouts to help you understand how to use the book more efficiently. |
| cosentyx instructions for use: Dermatologic Immunity Brian J. Nickoloff, Frank O. Nestle, 2008-01-01 Nickeloff (skin cancer research, Cardinal Bernardin Cancer Center, Chicago) and Nestle (cutaneous medicine and immunotherapy, King's College, London School of Medicine at Guy's, UK) assemble 19 review articles on autoimmune disease processes that affect the skin, covering both humoral and cellular immunity. The etiology, cellular and molecular mechanisms, therapeutic strategies, and pathophysiology of diseases such as psoriasis, dermatitis, cutaneous lupus erythematosus, vitiligo, and scleroderma are discussed by individuals in dermatology, genetics, immunology, and pathology who are based around the world. The book is aimed at clinical researchers, students, allergists, immunologists, dermatologists, and internists. |
| cosentyx instructions for use: Neutrophil-Mediated Skin Diseases: Immunology and Genetics Angelo Valerio Marzano, Dan Lipsker, Massimo Cugno, 2019-12-30 |
| cosentyx instructions for use: Multiple Myeloma and Other Plasma Cell Neoplasms Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos, 2018-02-16 This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenström’s macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management. |
| cosentyx instructions for use: Skin Barrier Function T. Agner, 2016-02-04 Although a very fragile structure, the skin barrier is probably one of the most important organs of the body. Inward/out it is responsible for body integrity and outward/in for keeping microbes, chemicals, and allergens from penetrating the skin. Since the role of barrier integrity in atopic dermatitis and the relationship to filaggrin mutations was discovered a decade ago, research focus has been on the skin barrier, and numerous new publications have become available. This book is an interdisciplinary update offering a wide range of information on the subject. It covers new basic research on skin markers, including results on filaggrin and on methods for the assessment of the barrier function. Biological variation and aspects of skin barrier function restoration are discussed as well. Further sections are dedicated to clinical implications of skin barrier integrity, factors influencing the penetration of the skin, influence of wet work, and guidance for prevention and saving the barrier. Distinguished researchers have contributed to this book, providing a comprehensive and thorough overview of the skin barrier function. Researchers in the field, dermatologists, occupational physicians, and related industry will find this publication an essential source of information. |
| cosentyx instructions for use: Medicine at a Glance: Core Cases Patrick Davey, 2010-11-08 Designed to support the best-selling third edition of Medicine at a Glance (9781405186162), Medicine at a Glance: Core Cases contains over 200 cases with self-assessment exercises and answers to aid understanding and test student knowledge. Following the structure of the main textbook, each chapter presents a number of clinical cases based on the textbook chapter’s content. This clinical knowledge is tested by a number of multiple choice self-assessment exercises which can then be applied to practical situations on the ward. Ideal for medical students and junior doctors, Medicine at a Glance: Core Cases: Features over 200 case studies and self-assessment exercises based on the best-selling Medicine at a Glance (9781405186162) Follows the structure of the main textbook - each chapter presents a number of clinical cases based on the textbook chapter’s content Includes free access to the online, interactive version featuring feedback and scoring at www.ataglanceseries.com/medicine This title is also available as a mobile App from MedHand Mobile Libraries. Buy it now from Google Play or the MedHand Store. For more information on the complete range of at a Glance titles, please visit: www.ataglanceseries.com |
| cosentyx instructions for use: Real Issues for COVID-19 Vaccine Immunization & Pregnancy, Breastfeeding Mothers Cheng Hoon Chew, Yan Yee Yip, Jiveswara Vijiakumar, Norzaihan Hassan, Muniswaran Ganeshan, Noel Thomas Ross, Kah Chuan Lim, Benedict Heng Sim Lim, Anusha Shunmugarajoo, Kalaiarasu Peariasamy, 2021-06-22 Healthcare professionals and high-risk pregnant mothers are vulnerable during COVID-19 pandemic. Most of them will be asymptomatic. The maternal and fetal implications of COVID-19 are significant. Vaccine has been proven to significantly reduce hospitalizations, complications and deaths. Dr. Muniswaran Ganeshan, a Maternal Fetal Medicine Consultant, Dr. Norzaihan binti Hassan, a Family Medicine Consultant and Datuk Dr. Noel Thomas Ross, the Head of Acute Medicine and Consultant Physician shared some insights in the phase 1 mass COVID-19 vaccination and current evidence, safety and COVID-19 vaccine concerns among pregnant and breastfeeding mothers. |
| cosentyx instructions for use: Therapy for Severe Psoriasis E-Book Jashin J. Wu, Steven R. Feldman, Mark Lebwohl, 2016-12-02 A brand-new title in the field of dermatology, Therapy for Severe Psoriasis provides the ultimate coverage of the treatment options available for today's most serious cases, including biologics and oral therapies. It features discussions of the newest drug therapies, recent FDA-approved biosimilars, and combination approaches to care, while an overview chapter was designed to aid those new to the field in understanding the nuances of difficult-to-treat subtypes of psoriasis. Comprehensive and focused, Therapy for Severe Psoriasis will be a welcome addition to the library of any dermatologist seeking in-depth information on the challenges of this condition. - Each of the 16 chapters includes either an in-depth focus on a single therapy or an overview of a unique aspect of psoriasis, including: UVB therapy, methotrexate, acitretin, cyclosporine, apremilast, etanercept, infliximab, adalimumab, ustekinumab, secukinumab, and ixekizumab. - Takes an evidence-based approach to hard-to-treat severe psoriasis. - Discusses the newest drug therapies (such as ixekizumab), plus recent FDA-approved biosimilars, a topic unique to this particular psoriasis text. - Presents combination approaches for instances when standard treatments are not successful. - Includes an overview chapter to help beginners understand the nuances of the disorder. |
| cosentyx instructions for use: The Paradox of the Immune System Louis J. Catania, 2022-08-06 The Paradox of the Immune System: Protection, Inflammation, Autoimmune Disease and Beyond provides a provocative approach to immunology as a double-edged sword. While it is our greatest protector, it is also the cause of chronic inflammation that leads to autoimmune disease, cancer and infectious diseases like COVID-19. Sections cover the basic science of immunology and its intimate genetic associations, biomedical hypotheses asserting immunology as the basis of all human diseases, and elaborate on immunology as the enemy within us. This engaging, original approach to a science so personal provides new and invaluable understanding on the bioscience that controls our lives. - Written in an expository style that allows for maximum understanding of the complex science presented - Presents the unfolding of immunology from a natural (innate) system into an adaptive system leading to chronic inflammation and ultimate disease - Provides readers with a unique perspective on health, wellness and disease |
| cosentyx instructions for use: Post-Translational Modifications in Health and Disease Cecilio J. Vidal, 2010-10-13 Post-translational modifications serve many different purposes in several cellular processes such as gene expression, protein folding and transport to appropriate cell compartment, protein-lipid and protein-protein interactions, enzyme regulation, signal transduction, cell proliferation and differentiation, protein stability, recycling and degradation. Although several-hundred different modifications are known, the significance of many of them remains unknown. The enormous versatility of the modifications which frequently alter the physico-chemical properties of the respective proteins represents an extraordinary challenge in understanding their physiological role. Since essential cellular functions are regulated by protein modifications, an improvement of current understanding of their meaning might allow new avenues to prevent and/or alleviate human and animal diseases. |
| cosentyx instructions for use: Skills in Rheumatology Hani Almoallim, Mohamed Cheikh, 2021-01-05 This Open Access book presents practical approaches to managing patients affected by various rheumatological diseases, allowing readers to gain a better understanding of the various clinical expressions and problems experienced by these patients. Discussing rheumatology from an organ systems perspective, it highlights the importance ofdetailed musculoskeletal examinations when treating patients affected by rheumatological diseases. The book first explores the latest diagnostic approaches and offers key tips for accurate musculoskeletal examinations before addressing the various treatment modalities, with a particular focus on the most common joints involved in rheumatoid arthritis: the wrists and the metacarpophalangeal joints (2nd and 3rd). Featuring easy-to-understand flow diagrams and explaining the common medical problems associated with rheumatic disease, such as shortness of breath and anemia, it is not only a valuable resource to rheumatologists, but will also appeal to medical students, junior residents, and primary healthcare physicians. |
Plaque Psoriasis Treatment | COSENTYX® (secukinumab)
#1 PRESCRIBED. COSENTYX is the #1 prescribed ‡ biologic treatment of its kind. § ‡ Across all indications combined. § Treatment for plaque psoriasis that targets IL-17A, one of the multiple …
Psoriatic Arthritis Treatment | COSENTYX® (secukinumab)
Results fast. Relief that can last. ‡ COSENTYX is proven to help reduce symptoms of psoriatic arthritis (PsA). 3 WEEKS, 5 YEARS, #1 PRESCRIBED:
Hidradenitis Suppurativa | COSENTYX® (secukinumab)
Real relief for people with HS 50% REDUCTION OF ABSCESSES & NO INCREASE IN THESE SYMPTOMS . In the 2 clinical trials, 41% and 43% of adults taking COSENTYX 300 mg every …
Secukinumab - Wikipedia
Secukinumab inhibits a member of the cytokine family, interleukin 17A, which is produced mainly by inflammatory T helper 17 cells. [11] IL17A is upregulated in serum of people with psoriasis …
Secukinumab (Cosentyx) Uses, Dosage, Side Effects, Warnings
May 16, 2025 · Secukinumab (Cosentyx) is an IL-17A blocker used to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, enthesitis-related arthritis, hidradenitis suppurativa …
GET THE FACTS ABOUT SAFETY AND SIDE EFFECTS - COSENTYX
COSENTYX is a medicine that affects your immune system. COSENTYX may increase your serious side effects such as: Infections COSENTYX may lower the ability of your immune …
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - Food and …
TM FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE COSENTYX is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are …
Injection Resources | COSENTYX® (secukinumab)
COSENTYX ® Connect is here for you throughout your treatment. COSENTYX ® Connect is a support program for people taking or considering COSENTYX. Sign up now for access to a full …
HOW DOES COSENTYX ® (secukinumab) WORK?
§Administered subcutaneously (under your skin). || Results shown in clinical trials using subcutaneous (SC) administration (injection under the skin). The FDA approval of the …
Cosentyx: Package Insert / Prescribing Info - Drugs.com
COSENTYX is a human interleukin-17A antagonist indicated for the treatment of: moderate to severe plaque psoriasis (PsO) in patients 6 years and older who are candidates for systemic …
How Does COSENTYX Work | COSENTYX® (secukinumab)
COSENTYX is a different kind of targeted biologic. It's the first and most prescribed treatment of its kind || and works within your body to target IL-17A. IL-17A is one of the multiple molecules …
label - Food and Drug Administration
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE . 1.1 Plaque Psoriasis . COSENTYX ® is indicated for the treatment of moderate to severe plaque psoriasis (PsO) in …
HOW DOES COSENTYX ® (secukinumab) WORK?
COSENTYX is the first FDA-approved biologic of its kind, an IL-17A blocker. What is a biologic? A biologic is a protein-based medication that is made from living sources and is taken by …
Secukinumab (Cosentyx®) - Johns Hopkins Arthritis Center
What is Secukinumab (Cosentyx®)? Secukinumab is a drug that reduces the signs and symptoms of psoriatic arthritis, ankylosing spondylitis, and psoriasis.
Plaque Psoriasis Treatment | COSENTYX® (secukinumab)
#1 PRESCRIBED. COSENTYX is the #1 prescribed ‡ biologic treatment of its kind. § ‡ Across all indications combined. § Treatment for plaque psoriasis that targets IL-17A, one of the multiple …
Psoriatic Arthritis Treatment | COSENTYX® (secukinumab)
Results fast. Relief that can last. ‡ COSENTYX is proven to help reduce symptoms of psoriatic arthritis (PsA). 3 WEEKS, 5 YEARS, #1 PRESCRIBED:
Hidradenitis Suppurativa | COSENTYX® (secukinumab)
Real relief for people with HS 50% REDUCTION OF ABSCESSES & NO INCREASE IN THESE SYMPTOMS . In the 2 clinical trials, 41% and 43% of adults taking COSENTYX 300 mg every …
Secukinumab - Wikipedia
Secukinumab inhibits a member of the cytokine family, interleukin 17A, which is produced mainly by inflammatory T helper 17 cells. [11] IL17A is upregulated in serum of people with psoriasis …
Secukinumab (Cosentyx) Uses, Dosage, Side Effects, Warnings
May 16, 2025 · Secukinumab (Cosentyx) is an IL-17A blocker used to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, enthesitis-related arthritis, hidradenitis suppurativa …
GET THE FACTS ABOUT SAFETY AND SIDE EFFECTS - COSENTYX
COSENTYX is a medicine that affects your immune system. COSENTYX may increase your serious side effects such as: Infections COSENTYX may lower the ability of your immune …
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - Food and …
TM FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE COSENTYX is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are …
Injection Resources | COSENTYX® (secukinumab)
COSENTYX ® Connect is here for you throughout your treatment. COSENTYX ® Connect is a support program for people taking or considering COSENTYX. Sign up now for access to a full …
HOW DOES COSENTYX ® (secukinumab) WORK?
§Administered subcutaneously (under your skin). || Results shown in clinical trials using subcutaneous (SC) administration (injection under the skin). The FDA approval of the …
Cosentyx: Package Insert / Prescribing Info - Drugs.com
COSENTYX is a human interleukin-17A antagonist indicated for the treatment of: moderate to severe plaque psoriasis (PsO) in patients 6 years and older who are candidates for systemic …
How Does COSENTYX Work | COSENTYX® (secukinumab)
COSENTYX is a different kind of targeted biologic. It's the first and most prescribed treatment of its kind || and works within your body to target IL-17A. IL-17A is one of the multiple molecules …
label - Food and Drug Administration
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE . 1.1 Plaque Psoriasis . COSENTYX ® is indicated for the treatment of moderate to severe plaque psoriasis (PsO) in …
HOW DOES COSENTYX ® (secukinumab) WORK?
COSENTYX is the first FDA-approved biologic of its kind, an IL-17A blocker. What is a biologic? A biologic is a protein-based medication that is made from living sources and is taken by …
Secukinumab (Cosentyx®) - Johns Hopkins Arthritis Center
What is Secukinumab (Cosentyx®)? Secukinumab is a drug that reduces the signs and symptoms of psoriatic arthritis, ankylosing spondylitis, and psoriasis.
